Form 4: Inari Medical Director Cynthia Lucchese Reports Acquisition of 4,126 Shares

Director Cynthia Lucchese reports acquiring 4,126 shares of Inari Medical, Inc. common stock at $42.41 per share on April 24, 2024.

Summary

• On April 24, 2024, Cynthia Lucchese, a director of Inari Medical, Inc., acquired 4,126 shares of common stock at a price of $42.41 per share.
• This transaction increased Lucchese's direct holdings to 38,429 shares.
• The acquisition was in the form of restricted stock units, which vest in full on the earlier of the day prior to the Issuer's next annual meeting of stockholders or one year from the date of grant.

Sentiment

Score: 6

Explanation: The sentiment is neutral. It's a routine disclosure of a stock transaction by a company director. The purchase itself is a mildly positive signal, but the document is primarily informational.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to track confidence levels and potential alignment of interests.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company insider.

Key Dates